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Using the saphenous vein graft in coronary artery by-pass grafting, the proximal anastomosis is usuallyperformed by running sutures with a partial occlusionclamp. This technique is bearing the risk of immediate
or delayed aortic dissection induced by the heel of a partial
occlusion clamp,1 especially in the case of a diseased aortic wall or
poor suturing technique.
If atheroma or calcification of the aortic wall are present,
clamping is often impossible, and it remains unclear whether the
use of the partial occlusion clamps on the pulsating aorta during
off-pump surgery will increase the risk of iatrogenic injuries.
However, the St Jude Medical, Inc, Symmetry Bypass System
(Aortic Connector System [ACS]) presents an alternative way of
creating the proximal anastomosis of saphenous vein grafts.2 It
avoids aortic bite clamping and reduces the need for aortic ma-
nipulation.
Patients and Methods
Between April and October 2001, 69 of 70 proximal anastomoses
were consecutively performed in 45 patients aged 36 to 89 years
(mean, 68.3 years) by using the ACS. Eighteen internal thoracic
artery grafts, 70 autologous vein grafts, and 1 radial artery graft
were used, for a total number of 108 peripheral anastomoses with
an average of 2.4 anastomoses per patient. Five patients were
operated on in a conventional manner with the heart-lung machine.
Of 31 off-pump patients, 9 patients had to be switched to on-pump
therapy, with a conversion rate of 29%.
In 4 patients with postoperatively de novo angina pectoris,
coronary angiography was indicated, showing severe stenosis of
the proximal anastomoses in each case.
In all cases the stenosis appeared several weeks after discharge
from the hospital. Three patients underwent a redo procedure using
the heart-lung machine and partial occlusion clamp, and one pa-
tient was treated by means of dilatation.
PATIENT 1. A 52-year-old woman had a history of dialysis since
1998 and 3-vessel disease. Preoperatively, she was treated with
nitrate and heparin because of unstable angina pectoris after 2
fruitless attempts at angioplasty of the right coronary artery
(RCA). There was no myocardial infarction. Ejection fraction was
74%. Elective on-pump coronary artery surgery was performed on
June 28, 2001, and indication for use of the ACS was a severe
calcified ascending aorta. Two single-vein grafts to the left anterior
descending coronary artery (LAD) and the posterior descending
coronary artery (PDA) were placed. A short time after discharge,
the patient had angina pectoris. Cardiac catheterization (September
19, 2001) showed an occlusion of the PDA bypass next to the
stenosed proximal ACS anastomosis (Figure 1), as well as a
subtotal stenosis of the proximal anastomosis of the ACS-LAD
graft (Figure 2). On September 21, the patient had an acute inferior
myocardial infarction and a maximum creatine kinase level of 400
U/L. Redo surgery was performed successfully on October 18,
2001, in a conventional manner by using cardiopulmonary bypass
and placing 2 single-vein grafts to the RCA and the marginal
branch of the circumflex artery, as well as the left internal thoracic
artery to the LAD. Histopathologic examination of the proximal
parts of the explanted PDA bypass showed severe intimal fibrosis,
as well as organized and partially revascularized thrombosis.
PATIENT 2. A 47-year-old woman was given a diagnosis of
2-vessel disease. She had a history of myocardial infarction, but
her ejection fraction was normal. The operation was performed on
April 24, 2001, placing 2 single-vein grafts to the RCA and
diagonal branch (Dg) by means of off-pump coronary surgery with
the ACS. The postoperative course was without any complications
until September 2001, when the patient again had angina pectoris.
Cardiac catheterization showed a severe stenosis of the proximal
anastomosis of both vein grafts (Figures 3 and 4), and redo surgery
was performed successfully on September 20, 2001, placing 2
single-vein grafts to the PDA, as well as to the Dg, in the conven-
tional method with a heart-lung machine and partial clamping.
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PATIENT 3. A 57-year-old man given a diagnosis of 2-vessel
disease underwent off-pump coronary surgery, placing one se-
quential vein graft to the Dg and to the proximal as well as the
distal part of the LAD (snake graft) on June 9, 2001, with the ACS.
The postoperative course was uneventful, and the patient was
discharged 6 days after surgical treatment.
At the end of 2001, he again had angina pectoris, and cardiac
catheterization showed a high-grade stenosis of the proximal (Fig-
ure 5) and peripheral anastomosis. Redo surgery was successfully
performed on January 7, 2002, by using cardiopulmonary bypass
and partial occlusion clamping.
PATIENT 4. A 78-year-old man was given a diagnosis of 2-ves-
sel disease, and he had an ejection fraction of 24%. Preoperatively,
Figure 2. High-grade stenosis of the proximal vein graft anasto-
mosis to the LAD performed with the ACS.
Figure 3. High-grade stenosis of the proximal vein graft anasto-
mosis to the RCA related to the ACS.
Figure 4. Stenosis of the proximal anastomosis of the saphenous
vein graft to the Dg performed with the ACS.
Figure 1. Occlusion of the saphenous vein graft to the posterior
descending coronary artery next to the stenosed proximal ACS
anastomosis.
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the patient reported unstable angina pectoris. Coronary surgery
was performed on April 4, 2001, by using conventional cardiopul-
monary bypass. A sequential vein graft was placed to the Dg and
LAD by using the ACS for severe calcification of the aorta. A
further single graft was placed to the marginal branch of the
circumflex artery with a venovenous anastomosis to the LAD-Dg
graft. A short time after discharge, he again had angina pectoris.
Cardiac catheterization showed a high-grade stenosis of the
LAD-Dg graft proximal to the venovenous anastomosis (Figure 6).
Successful dilatation and stenting of the stenosis was done on June
13, 2001. In December 2001, the patient was admitted again
because of recurrent unstable angina pectoris. Cardiac catheteriza-
tion showed a high-grade stenosis of the proximal anastomosis of
the LAD-Dg graft related to the ACS (Figure 7), which was dilated
and stented successfully on December 7, 2001.
Discussion
Using a partial occlusion clamp for proximal anastomosis in aorta-
coronary bypass surgery bears the risk of iatrogenic dissections or
embolic complications for various reasons. These complications
are more likely in patients with the risk factors of atheroma,
calcification, medial necrosis, a thin fragile aorta, or an increased
wall tension during off-pump surgery.1 St Jude Medical, Inc, offers
a novel sutureless connector system for creation of the proximal
anastomosis of saphenous vein grafts without the need for clamp-
ing of the aorta.2 The vein hook is made of nickel titanium
(Nitinol), a biocompatible alloy, and published results show that
the ACS does not seem to impair endothelial function.*
However, 4 of 45 patients treated with the ACS between April
2001 and October 2001 had a proximal ACS-related stenosis,
thrombosis of the saphenous vein graft, or both, with the need for
reintervention within 6 months postoperatively. One resected vein
graft showed a partially revascularized thrombosis of the proximal
graft. Genesis of the stenoses is unknown. We did not observe any
kinking of any of the implanted grafts at the aortic take-off point
as a probable cause. A possible explanation could be the unavoid-
*Verma S, Ko L, Fedak PWM, Cusimano RJ, Yau T. The St Jude Medical
sutureless aortic anastomotic connector does not impair endothelial function in
human saphenous veins. Unpublished data.
Figure 6. High-grade stenosis of the LAD-Dg graft in the middle
part of the bypass proximal to venovenous anastomosis.
Figure 7. Stenosis of the proximal anastomosis of the LAD-Dg
graft related to the ACS.
Figure 5. High-grade stenosis of the proximal anastomosis of the
sequential LAD-Dg vein graft related to the ACS.
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able learning curve, resulting in an undersizing or oversizing or the
incomplete piercing of the saphenous vein, followed by rolling up
of the intima and resulting thereby in graft stenosis or occlusion,
mechanical alteration of the intima itself, or bioincompatibility of
the device. The significance of the ACS in the genesis of proximal
graft stenosis, thrombosis, or both has to be elucidated by means of
further investigations.
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The last to die is hope: Prolonged
mechanical circulatory support with a
Novacor left ventricular assist device as a
bridge to transplantation
Dino Casarotto, MD, Tomaso Bottio, MD, Antonio Gambino, MD,
Luca Testolin, MD, and Gino Gerosa, MD, Padua, Italy
In September 1996 a 31-year-old man was admitted to PaduaHospital, Padua, Italy, in cardiogenic shock that was notresponsive to medical treatment and intra-aortic balloonpump insertion. The patient had Castleman disease, and in
1989 he was treated with cycles of cyclophosphamide, vincristine,
mitoxantrone hydrochloride (INN: mitoxantrone), and interferon.
In June 1996 at another hospital, he had postchemotherapy dilated
cardiomyopathy diagnosed, with akinesia of septum and anterior
left ventricle wall (end-diastolic volume 230 mL, end-systolic
volume 180 mL, ejection fraction 20%, and left ventricular end-
diastolic diameter 67 mm). Because of severe left ventricular
failure, we started therapy with a BioMedicus left ventricular assist
device (Medtronic BioMedicus, Inc, Minneapolis, Minn) and an
intra-aortic balloon pump. In October 1996 we converted the
centrifugal pump support to a Novacor left ventricular assist sys-
tem (World Heart Novacor LVAS N100 PCq; World Heart Cor-
poration, Ottawa, Ontario, Canada) because of the impossibility of
weaning the patient from the BioMedicus pump and the risks
associated with heart transplantation related to potential relapse of
neoplastic disease (chest computed tomographic scan with medi-
astinal lymph nodes  2 cm).
The Novacor left ventricular assist system, a device used for
patients with cardiogenic shock, is considered an interim system to
be used before transplantation or to achieve left ventricular recov-
ery for patients who are not candidates for transplantation.1 In the
long term the main disadvantages of this device are driveline
infections, thromboembolism, and system failures affecting the
pump and valves.2
During the patient’s recovery period, he had several episodes of
pocket driveline infections and one episode of cerebral embolism,
all with complete recovery (no abnormal findings on cerebral
computed tomographic scan at follow-up). After the patient had
been supported by the Novacor device for 24 months, we at-
tempted to wean him from the system but were unable to do so. In
June 2000, the patient showed moderate dyspnea with symptoms
of congestive heart failure that necessitated angiotensin-converting
enzyme inhibitors and diuretics. A 2-dimensional Doppler echo-
cardiographic evaluation showed moderate incompetence of the
Novacor inflow valve. After 50 months of successful mechanical
circulatory support (December 5, 2000), there were no signs indi-
cating a relapse of Castleman disease, and we were able to perform
orthotopic heart transplantation.
As a result of chemotherapy for Castleman disease, this patient
had marked variations in myocardial cells, as seen in the endo-
myocardial biopsy specimen, with great areas of interstitial fibrosis
that caused left ventricular dysfunction. Because of the possibility
of myocardial function recovery and the high rate of neoplastic
lesions seen in other transplant recipients after immunosuppressive
therapy,3 rather than perform an orthotopic heart transplant we
supported the patient with a mechanical Novacor device. With the
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